When would you consider active surveillance for a patient with metastatic RCC?
NCCN include active surveillance as an option in specific circumstances based on Rini et al. (Lancet Oncology 2016) however this set is not well defined as the study left it for the discretion of treating MD.
Answer from: Medical Oncologist at Academic Institution
Factors I consider when deciding upon active surveillence include patient comorbidities, pace of disease, location of disease, and symptoms related to disease.
I will typically consider a patient for active surveillence if:
the time from nephrectomy --> radiographically evident disease is >...
Comments
Medical Oncologist at Vanderbilt-Ingram Cancer Center I agree. The precise characteristics of patients s...
I agree. The precise characteristics of patients s...